Marks, who formerly oversaw approval of new vaccines and gene therapies at the US Food and Drug Administration, was forced out of his post in March. In his
Starting this month, Marks will become Lilly’s senior vice president of molecule discovery and its head of infectious diseases, a spokesperson for the company said.
“Peter’s expertise strengthens ...
Learn more about Bloomberg Law or Log In to keep reading:
Learn About Bloomberg Law
AI-powered legal analytics, workflow tools and premium legal & business news.
Already a subscriber?
Log in to keep reading or access research tools.